ロード中...
Plasma phospho-tau181 increases with Alzheimer’s disease clinical severity and is associated with tau-PET and amyloid-PET
INTRODUCTION: We examined and compared plasma phospho-tau181 (pTau181) and total tau: 1) across the Alzheimer’s disease (AD) clinical spectrum; 2) in relation to brain amyloid (Aβ) PET, tau PET, and cortical thickness; and 3) as a screening tool for elevated brain Aβ. METHODS: Participants included...
保存先:
| 出版年: | Alzheimers Dement |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6097897/ https://ncbi.nlm.nih.gov/pubmed/29626426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2018.02.013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|